@swissinitiativerna.bsky.socialMeet three confirmed speakers for RNATX 2027: Daniel Blessing (HAYA Therapeutics, keynote), Christian Berk (E.Blum & Co AG) and Felix Gnerlich (Ribocure Pharmaceutical AB).
Join us in Bern on 28 January 2027.
Register: www.conftool.net/chrnat2027
More info: rnatx.ch
@otdc-2026.bsky.social⏳ 1 st Round Abstract deadline: Sept 23!
Working in oligonucleotide therapeutics, RNA, drug delivery, or CRISPR? Share your research at #OTDC2027, May 11–12, Boston + virtual.
Submit: oligo-nucleotide.com/abstract-sub...
Know someone interested? Share! #RNAResearch
@otdc-2026.bsky.social🔬 “Design the molecule. Refine the delivery. Expand the possibilities.”
Discover emerging directions in oligonucleotide therapeutics and RNA-based medicines at OTDC 2027.
📅 May 11–12, 2027 | Boston, Massachusetts | Hybrid
🔗 oligo-nucleotide.com
@swissinitiativerna.bsky.socialRegistration is now open for the 4th Swiss RNA Therapeutics Summit!
Join researchers, clinicians and industry partners in Bern on 28 January 2027 for a full day dedicated to RNA therapeutics.
Register: www.conftool.net/chrnat2027
@d2rmcgill.bsky.social🎉 Congratulations to the recipients of the 2026 D2R Scholar Awards!
This year, D2R is supporting 30 outstanding Master's and Doctoral students conducting innovative #RNAResearch at @mcgill.ca, @uottawa.ca, UBC, and @usherbrooke.bsky.social.
@otdc-2026.bsky.social🧬 Discover the evolving landscape of oligonucleotide therapeutics, RNA medicines, and next-generation delivery technologies at OTDC 2027.
📅 May 11–12, 2027
📍 Boston, Massachusetts, USA | Hybrid
🔗 oligo-nucleotide.com
#OTDC2027 #Oligonucleotides #RNATherapeutics #mRNA #DrugDelivery #RNAResearch
